EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Genetic variation of the 5‐HT1A rs6295, 5‐HT2A rs6311, and CNR1 rs1049353 and an altered endocannabinoid system in depressed patients

Jasmin Obermanns, Hanna Meiser, Saskia Hoberg, Cynthia Segura Vesterager iD, Frank Schulz iD, Georg Juckel, Barbara Emons iD

Brain and Behavior · 2023

DOI: 10.1002/brb3.3323 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Brain and Behavior, 2023. Verfasst von Jasmin Obermanns und 6 weiteren Autor:innen. Beteiligte Einrichtung: LWL University Hospital, Department of Psychiatry, Psychotherapy and Preventive Medicine, Ruhr University Bochum, Bochum, Germany. Hauptthemen laut MEDLINE: Endocannabinoids, Polyunsaturated Alkamides. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 73 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: FoRUM Research Programme of the Faculty of Medicine, Ruhr University Bochum.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

The reasons for developing depression are not fully understood. However, it is known that the serotonergic system plays a role in the etiology, but the endocannabinoid system receives attention.

Method

In this study, 161 patients with a depressive disorder and 161 healthy participants were examined for the distribution of the CNR1 rs4940353, 5‐HT2A rs6311, and 5‐HT1A rs6295 by high‐resolution melting genotyping. The concentration of arachidonoyl ethanolamide (AEA) and 2‐arachidonoylglycerol (2‐AG) in the blood was measured by liquid chromatography–tandem mass spectrometry. Additionally, depression and anxiety symptoms were evaluated based on self‐questionnaires. Fifty‐nine patients participated in a second appointment to measure the concentration of AEA, 2‐AG, and symptoms of depression and anxiety.

Results

We observed higher AEA and decreased 2‐AG concentrations in patients with depression compared to healthy participants. During the treatment, the concentrations of AEA and 2‐AG did not change significantly. In patients higher symptoms of anxiety correlated with lower concentrations of 2‐AG. Gender differences were found concerning increased 2‐AG concentration in male patients and increased anxiety symptoms in female patients. Genotypic variations of 5‐HT1A rs6295 and 5‐HT2A rs6311 are associated with altered serotonergic activity and serotonin content in patients.

Conclusion

In conclusion, it seems that the endocannabinoid system, especially the endocannabinoids 2‐AG and AEA, and genetic variations of the 5‐HT1A and 5‐HT2A could play a role in patients with depression and may be involved in a depressive disorder.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

EndocannabinoidsPolyunsaturated AlkamidesFemaleHumansMaleChromatography, LiquidGenetic VariationReceptor, Cannabinoid, CB1Arachidonic AcidsReceptor, Serotonin, 5-HT1AReceptor, Serotonin, 5-HT2A

Stichwörter der Autor:innen

2-arachidonoylglycerolarachidonoyl ethanolamidecannabinoid receptordepressionserotonin receptor

Substanzen

EndocannabinoidsPolyunsaturated AlkamidesReceptor, Cannabinoid, CB1anandamideArachidonic AcidsCNR1 protein, humanHTR1A protein, humanReceptor, Serotonin, 5-HT1AHTR2A protein, humanReceptor, Serotonin, 5-HT2A

Autor:innen und Institutionen

  • LWL University Hospital, Department of Psychiatry, Psychotherapy and Preventive Medicine, Ruhr University Bochum, Bochum, Germany.
  • Chemistry and Biochemistry of Natural Products, Ruhr University Bochum, Bochum, Germany.

ORCID-Profile: Cynthia Segura Vesterager, Frank Schulz, Barbara Emons

Förderung

  • FoRUM Research Programme of the Faculty of Medicine, Ruhr University Bochum

Zitieren

APA

Obermanns, J., Meiser, H., Hoberg, S., Vesterager, C. S., Schulz, F., Juckel, G., & Emons, B. (2023). Genetic variation of the 5‐HT1A rs6295, 5‐HT2A rs6311, and CNR1 rs1049353 and an altered endocannabinoid system in depressed patients. Brain and Behavior. https://doi.org/10.1002/brb3.3323

Vancouver

Obermanns J, Meiser H, Hoberg S, Vesterager CS, Schulz F, Juckel G, et al. Genetic variation of the 5‐HT1A rs6295, 5‐HT2A rs6311, and CNR1 rs1049353 and an altered endocannabinoid system in depressed patients. Brain and Behavior. 2023. doi:10.1002/brb3.3323

BibTeX
@article{Obermanns2023,
  author = {Obermanns, Jasmin and Meiser, Hanna and Hoberg, Saskia and Vesterager, Cynthia Segura and Schulz, Frank and Juckel, Georg and Emons, Barbara},
  title = {Genetic variation of the 5‐HT1A rs6295, 5‐HT2A rs6311, and CNR1 rs1049353 and an altered endocannabinoid system in depressed patients},
  journal = {Brain and Behavior},
  year = {2023},
  doi = {10.1002/brb3.3323}
}
Kostenlos starten →